Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Private Placement	Private Placement Common Stock	Private Placement Additional Paid In Capital	IPO	IPO Common Stock	IPO Additional Paid In Capital
Beginning Balance at Dec. 31, 2020	$ 283,888	$ 4	$ 412,777	$ (128,765)	$ (128)
Beginning Balance at Dec. 31, 2020		44,482,186
Exercise of Stock Options	7,633	$ 1	7,632
Exercise of Stock Options, Shares		1,431,271
Vesting Restricted Stock, Shares		72,359
Stock-based compensation expense	24,972		24,972
Unrealized gain on marketable securities	(532)				(532)
Issuance of shares						$ 2,346		$ 2,346	$ 240,760		$ 240,760
Issuance of shares, Shares							49,928			5,468,250
Net Income (Loss)	(100,217)			(100,217)
Issuance of shares under employee stock purchase plan, Value	788		788
Issuance of shares under employee stock purchase plan, Share		19,687
Issuance of vested restricted stock to consultants, Share		12,500
Ending Balance at Dec. 31, 2021	459,638	$ 5	689,275	(228,982)	(660)
Ending Balance, Shares at Dec. 31, 2021		51,536,181
Exercise of Stock Options	3,154		3,154
Exercise of Stock Options, Shares		601,594
Vesting Restricted Stock, Shares		36,866
Stock-based compensation expense	35,480		35,480
Unrealized gain on marketable securities	(4,289)				(4,289)
Net Income (Loss)	(154,808)			(154,808)
Issuance of shares under employee stock purchase plan, Value	1,150		1,150
Issuance of shares under employee stock purchase plan, Share		95,511
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance cost of $174	149,826	$ 1	149,825
Issuance of Common Stock at Private Placement, net of issuance cost, shares		2,769,228
Ending Balance at Dec. 31, 2022	490,151	$ 6	878,884	(383,790)	(4,949)
Ending Balance, Shares at Dec. 31, 2022		55,039,380
Exercise of Stock Options	2,860		2,860
Exercise of Stock Options, Shares		441,759
Vesting Restricted Stock, Shares		39,511
Stock-based compensation expense	43,118		43,118
Unrealized gain on marketable securities	4,397				4,397
Net Income (Loss)	(146,962)			(146,962)
Issuance of shares under employee stock purchase plan, Value	1,407		1,407
Issuance of shares under employee stock purchase plan, Share		64,655
Ending Balance at Dec. 31, 2023	$ 394,971	$ 6	$ 926,269	$ (530,752)	$ (552)
Ending Balance, Shares at Dec. 31, 2023		55,585,305